| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/28/2013 | EP2630493A2 Antigen-specific, tolerance-inducing microparticles and uses thereof |
| 08/28/2013 | EP2630242A1 Identification of antibodies specific for lyssaviruses and methods of their use |
| 08/28/2013 | EP2630238A1 Wdhd1 peptides and vaccines including the same |
| 08/28/2013 | EP2630237A1 C18orf54 peptides and vaccines including the same |
| 08/28/2013 | EP2630162A2 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 08/28/2013 | EP2630160A1 Erbb3 binding antibody |
| 08/28/2013 | EP2629798A2 Anti-folate receptor alpha antibody glycoforms |
| 08/28/2013 | EP2629797A2 Peptides for modulating t-cell activity and uses thereof |
| 08/28/2013 | EP2629795A2 Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease |
| 08/28/2013 | EP2629794A1 Herpesvirus of turkeys vectored vaccine against avian influenza in poultry |
| 08/28/2013 | EP2629793A1 Chlamydia antigens and uses thereof |
| 08/28/2013 | EP2629792A1 Method of storing a vaccine containing an aluminum adjuvant |
| 08/28/2013 | EP2629791A1 Her2 dna vaccine as adjunct treatment for cancers in companion animals |
| 08/28/2013 | EP2629788A2 Use of human serum albumin to decrease antigenicity of therapeutic proteins |
| 08/28/2013 | EP2629787A1 Selective targeting of the cd40l/mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis |
| 08/28/2013 | EP2157192B1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) |
| 08/28/2013 | CN103270159A Immunostimulatory oligodeoxynucleotides |
| 08/28/2013 | CN103270156A Wdhd1 peptides and vaccines including the same |
| 08/28/2013 | CN103270048A New adjuvant |
| 08/28/2013 | CN103270047A Oprf/i agents and their use in hospitalized and other patients |
| 08/28/2013 | CN103270040A High-efficiency catalysts, preparation and use thereof |
| 08/28/2013 | CN103269719A Immunogenic compositions and methods for treating neurologic disorders |
| 08/28/2013 | CN103269718A Pharmaceutical formulation comprising a biopharmaceutical drug |
| 08/28/2013 | CN103269717A Gas-filled microvesicles for use as vaccine |
| 08/28/2013 | CN103269716A Lyophilized viral formulations |
| 08/28/2013 | CN103269715A Method for improving the production of influenza viruses and vaccine seeds |
| 08/28/2013 | CN103269714A Newcastle disease virus vectored herpesvirus vaccines |
| 08/28/2013 | CN103269713A Antigen delivery platforms |
| 08/28/2013 | CN103269712A Cytotoxic agents comprising new ansamitocin derivatives |
| 08/28/2013 | CN103269711A Vaccines based on peptides of the complement protein C5a |
| 08/28/2013 | CN103269710A Top2a inhibition by temozolomide useful for predicting gbm patient's survival |
| 08/28/2013 | CN103266113A DNA (deoxyribonucleic acid) aptamer capable of specifically bonding with BCG (bacillus Calmette-Gue'rin) glycolipid antigen and application of DNA aptamer |
| 08/28/2013 | CN103266091A A type foot-and-mouth disease recombinant vaccine strains and preparation method and application thereof |
| 08/28/2013 | CN103266090A Asia1 type foot-and-mouth disease recombinant virus and preparation method and application thereof |
| 08/28/2013 | CN103265631A Heavy chain and light chain variable regions of anti-human CRT monoclonal antibody |
| 08/28/2013 | CN103265627A HPV16L1-g protein and coding gene and application thereof |
| 08/28/2013 | CN103265626A HPV16L1-f protein and coding gene and application thereof |
| 08/28/2013 | CN103265625A HPV16L1-h protein and coding gene and application thereof |
| 08/28/2013 | CN103263667A Chicken infectious bursal disease live vaccine and production method thereof |
| 08/28/2013 | CN103263666A Duplex inactivated vaccine of porcine circovirus type 2 and porcine mycoplasma hyopneumoniae and preparation method of duplex inactivated vaccine |
| 08/28/2013 | CN103263665A Aphanothece halophytica expolysaccharide immunoadjuvant |
| 08/28/2013 | CN103263664A Method for preventing and treating alzheimer's disease |
| 08/28/2013 | CN102839158B Canine distemper attenuated vaccine strain and medical purpose |
| 08/28/2013 | CN102727904B Heat resisting protective agent of bivalent live vaccine against highly pathogenic porcine reproductive and respiratory syndrome-pseudorabies and preparation method thereof |
| 08/28/2013 | CN102727903B Heatproof lyophilized protective agent for live vaccine JXA1-R strain for highly pathogenic porcine reproductive and respiratory syndrome and method for preparing the same |
| 08/28/2013 | CN102277367B Duck viral enteritis viral vaccine strain infective cloned system, its construction method and its application |
| 08/28/2013 | CN102277330B Human CD3+CD8+gamma delta T lymphocyte, as well as preparation method and application thereof |
| 08/28/2013 | CN102250243B Antibody to interleukins-15 |
| 08/28/2013 | CN102114243B Method for preparing polyvalent vaccine of primary hamster kidney cells of flu |
| 08/28/2013 | CN101861167B Vaccine comprising monocyte or immature myeloid cells(IMC) which were loaded with the ligand of natural killer t cell and antigen |
| 08/28/2013 | CN101721695B Novel trivalent inactivated vaccine for swine streptococcosis |
| 08/28/2013 | CN101516359B Medicament for LCT poisoning |
| 08/28/2013 | CN101119745B Lectin compositions and methods for modulating an immune response to an antigen |
| 08/27/2013 | US8519118 RIP140 regulation of glucose transport |
| 08/27/2013 | US8519109 Tumour rejection antigens |
| 08/27/2013 | US8518905 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disorders |
| 08/27/2013 | US8518903 Use of toll-like receptor-9 agonists |
| 08/27/2013 | US8518889 Method of treating cancer with antibodies against long-form leukotriene B4 receptor BLT2 |
| 08/27/2013 | US8518888 Method of treatment of gastrointestinal-type cancer with antagonistic antibodies to IL-11R |
| 08/27/2013 | US8518873 Method of inhibiting clostridium difficile by administration of oritavancin |
| 08/27/2013 | US8518871 Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
| 08/27/2013 | US8518697 Single chain trimers and uses therefor |
| 08/27/2013 | US8518694 Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV |
| 08/27/2013 | US8518657 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides |
| 08/27/2013 | US8518655 Means for the diagnosis and therapy of CTCL |
| 08/27/2013 | US8518417 Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity |
| 08/27/2013 | US8518416 Compositions and methods for treatment of microbial infections |
| 08/27/2013 | US8518415 Engineered type IV pilin of Clostridium difficile |
| 08/27/2013 | US8518410 Fusion protein with HIV antigen |
| 08/27/2013 | US8518409 System for selective cell treatment using ideotypically modulated pharmacoeffectors |
| 08/27/2013 | US8518408 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infection |
| 08/27/2013 | US8518407 Therapeutic human anti-IL-1R1 monoclonal antibody |
| 08/27/2013 | US8518406 Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE) |
| 08/27/2013 | US8518405 Tumor specific antibodies and uses therefor |
| 08/27/2013 | US8518404 Activatable binding polypeptides and methods of identification and use thereof |
| 08/27/2013 | US8518403 Expression-enhanced polypeptides |
| 08/27/2013 | US8518401 Treating inflammatory diseases with antibodies that inhibit fractalkine-CXCR1 interaction |
| 08/27/2013 | US8518372 Coronin 1 modulators for the treatment of autoimmune and Lymphoproliferative disorders and mycobacterial infections |
| 08/27/2013 | US8517723 Methods for drying a viral vaccine |
| 08/27/2013 | CA2613818C Anti-il-23 antibodies, compositions, methods and uses |
| 08/27/2013 | CA2568015C Influenza hemagglutinin and neuraminidase variants |
| 08/27/2013 | CA2558371C Methods of modulating immune responses by modulating tim-1 and tim-4 function |
| 08/27/2013 | CA2526212C Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 08/27/2013 | CA2508773C Canine rankl and methods for preparing and using the same |
| 08/27/2013 | CA2486918C Novel chimeric cd154 |
| 08/27/2013 | CA2403425C Multivalent antibodies and uses therefor |
| 08/26/2013 | DE202013005100U1 Influenza Virus Reassortierung Influenza virus reassortment |
| 08/22/2013 | WO2013123478A1 Use of immunomodulators for the treatment of cancer |
| 08/22/2013 | WO2013123412A1 Conformation-stabilized trap antigens |
| 08/22/2013 | WO2013123242A1 Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom |
| 08/22/2013 | WO2013123219A1 Rotavirus subunit vaccines and methods of making and use thereof |
| 08/22/2013 | WO2013123193A1 Pyruvate kinase m2 neutralizing antibodies for inhibiting angiogenesis |
| 08/22/2013 | WO2013123152A2 ANTIBODIES TO INTEGRIN αVβ6 AND USE OF SAME TO TREAT CANCER |
| 08/22/2013 | WO2013122976A1 Osteopontin isoform a inhibitors and methods of use |
| 08/22/2013 | WO2013122827A1 Computationally optimized broadly reactive antigens for human and avian h5n1 influenza |
| 08/22/2013 | WO2013122545A1 Synergistic combinations for use in treating cancer |
| 08/22/2013 | WO2013122262A1 Virus like particle composition |
| 08/22/2013 | WO2013121441A2 Synthetic peptides capable of binding to influenza hemagglutinin protein |
| 08/22/2013 | WO2013121296A1 Erythrocyte-binding therapeutics |
| 08/22/2013 | WO2013121214A1 Reduction of gastrointestinal tract colonisation by campylobacter |